Raymond James Financial Services Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$126K Buy
+10,529
New +$91K ﹤0.01% 3256
2023
Q4
Sell
-31,770
Closed -$105K 3320
2023
Q3
$105K Sell
31,770
-324
-1% -$1.14K ﹤0.01% 3055
2023
Q2
$92.8K Sell
32,094
-1,298
-4% -$2.49K ﹤0.01% 3072
2023
Q1
$35.7K Sell
33,392
-1,301
-4% -$2.49K ﹤0.01% 3149
2022
Q4
$90.5K Sell
34,693
-8,723
-20% -$38.1K ﹤0.01% 3023
2022
Q3
$304K Buy
43,416
+4,433
+11% +$34.7K ﹤0.01% 2563
2022
Q2
$266K Sell
38,983
-227
-0.6% -$2.32K ﹤0.01% 2675
2022
Q1
$553K Sell
39,210
-422
-1% -$5.65K ﹤0.01% 2322
2021
Q4
$574K Buy
+39,632
New +$563K ﹤0.01% 2306

Other funds holding BVS